LymphedemaV1, PascalFrancis, Checkpoint, bibRecord, 000307

Risk factors for arm lymphedema following breast cancer diagnosis in Black women and White women

Identifieur interne : 000307 ( PascalFrancis/Checkpoint ); précédent : 000306; suivant : 000308

Risk factors for arm lymphedema following breast cancer diagnosis in Black women and White women

Auteurs : Kathleen A. Meeske [États-Unis] ; Jane Sullivan-Halley [États-Unis] ; Ashley W. Smith [États-Unis] ; Anne Mctiernan [États-Unis] ; Kathy B. Baumgartner [États-Unis] ; Linda C. Harlan [États-Unis] ; Leslie Bernstein [États-Unis]

Source :

Breast cancer research and treatment [ 0167-6806 ] ; 2009.

RBID : Pascal:09-0141950

Descripteurs français

Pascal (Inist)
- Facteur risque, Epidémiologie, Bras, Lymphoedème, Cancer du sein, Diagnostic, Négroïde, Race, Homme, Femelle, Adulte, Femme, Caucasoïde, Survivant, Hypertension artérielle, Indice masse corporelle.
Wicri :
- topic : Homme, Adulte, Femme.

English descriptors

KwdEn :
- Adult, Arm, Body mass index, Breast cancer, Caucasoid, Diagnosis, Epidemiology, Female, Human, Hypertension, Lymphedema, Negroid, Race, Risk factor, Survivor, Woman.

Abstract

Purpose Lymphedema of the arm is a potential complication of breast cancer therapy. This study examines pre-disposing factors that may operate in conjunction with treatment-related factors in the development of arm lymphedema in a large cohort of White and Black breast cancer survivors. Methods 494 women (271 White and 223 Black) with in situ to Stage III-A primary breast cancer completed a baseline interview within 18 months of diagnosis. Information on lymphedema was collected during a follow-up interview, conducted on average 50 months after diagnosis. Self-reported data were used to classify women with or without lymphedema. Multivariable logistic regression models were developed to identify risk factors for arm lymphedema. Results Arm lymphedema was associated with younger age at diagnosis (odds ratio, OR per year of age = 0.96; 95% confidence interval, CI = 0.93-0.99), positive history of hypertension (OR = 2.31; 95% CI = 1.38-3.88), obesity (OR for body mass index, BMI>30 = 2.48; 95% CI = 1.05-5.84) and having had surgery where 10 or more lymph nodes were excised (OR = 2.16; 95% CI = 1.12-4.17). While Black women had higher prevalence of arm lymphedema than White women (28% vs. 21%), race was not associated with lymphedema risk in models adjusted for multiple factors (adjusted OR = 1.01; 95% CI = 0.63-1.63). Conclusion Risk of arm lymphedema did not differ significantly for Black and White women. Risk factors identified in this study offer opportunities for interventions (weight loss, control of blood pressure, use of sentinel node biopsy where possible) for reducing incidence of lymphedema or controlling the symptoms associated with this condition.

Affiliations:

Links toward previous steps (curation, corpus...)

to stream PascalFrancis, to step Corpus: 000340
to stream PascalFrancis, to step Curation: 000618

Links to Exploration step

Pascal:09-0141950

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Risk factors for arm lymphedema following breast cancer diagnosis in Black women and White women</title>
<author><name sortKey="Meeske, Kathleen A" sort="Meeske, Kathleen A" uniqKey="Meeske K" first="Kathleen A." last="Meeske">Kathleen A. Meeske</name>
<affiliation wicri:level="4"><inist:fA14 i1="01"><s1>Department of Preventive Medicine, Keck School of Medicine of the University of Southern California</s1>
<s2>Los Angeles, CA</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Californie</region>
<settlement type="city">Los Angeles</settlement>
</placeName>
<orgName type="university">Université de Californie du Sud</orgName>
</affiliation>
</author>
<author><name sortKey="Sullivan Halley, Jane" sort="Sullivan Halley, Jane" uniqKey="Sullivan Halley J" first="Jane" last="Sullivan-Halley">Jane Sullivan-Halley</name>
<affiliation wicri:level="4"><inist:fA14 i1="01"><s1>Department of Preventive Medicine, Keck School of Medicine of the University of Southern California</s1>
<s2>Los Angeles, CA</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Californie</region>
<settlement type="city">Los Angeles</settlement>
</placeName>
<orgName type="university">Université de Californie du Sud</orgName>
</affiliation>
<affiliation wicri:level="2"><inist:fA14 i1="02"><s1>Department of Cancer Etiology, Division of Population Sciences, City of Hope National Medical Center and Comprehensive Cancer Center, 1500 Duarte Road, Bldg. 173</s1>
<s2>Duarte, CA 91010</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Californie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Smith, Ashley W" sort="Smith, Ashley W" uniqKey="Smith A" first="Ashley W." last="Smith">Ashley W. Smith</name>
<affiliation wicri:level="2"><inist:fA14 i1="03"><s1>Applied Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute</s1>
<s2>Bethesda, MD</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Maryland</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Mctiernan, Anne" sort="Mctiernan, Anne" uniqKey="Mctiernan A" first="Anne" last="Mctiernan">Anne Mctiernan</name>
<affiliation wicri:level="2"><inist:fA14 i1="04"><s1>Cancer Prevention Research Program, Fred Hutchinson Cancer Research Center</s1>
<s2>Seattle, WA</s2>
<s3>USA</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Washington (État)</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Baumgartner, Kathy B" sort="Baumgartner, Kathy B" uniqKey="Baumgartner K" first="Kathy B." last="Baumgartner">Kathy B. Baumgartner</name>
<affiliation wicri:level="2"><inist:fA14 i1="05"><s1>Department of Epidemiology & Population Health, University of Louisville</s1>
<s2>Louisville, KY</s2>
<s3>USA</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Kentucky</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Harlan, Linda C" sort="Harlan, Linda C" uniqKey="Harlan L" first="Linda C." last="Harlan">Linda C. Harlan</name>
<affiliation wicri:level="2"><inist:fA14 i1="03"><s1>Applied Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute</s1>
<s2>Bethesda, MD</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Maryland</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Bernstein, Leslie" sort="Bernstein, Leslie" uniqKey="Bernstein L" first="Leslie" last="Bernstein">Leslie Bernstein</name>
<affiliation wicri:level="4"><inist:fA14 i1="01"><s1>Department of Preventive Medicine, Keck School of Medicine of the University of Southern California</s1>
<s2>Los Angeles, CA</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Californie</region>
<settlement type="city">Los Angeles</settlement>
</placeName>
<orgName type="university">Université de Californie du Sud</orgName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">09-0141950</idno>
<date when="2009">2009</date>
<idno type="stanalyst">PASCAL 09-0141950 INIST</idno>
<idno type="RBID">Pascal:09-0141950</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000340</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000618</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000307</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000307</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Risk factors for arm lymphedema following breast cancer diagnosis in Black women and White women</title>
<author><name sortKey="Meeske, Kathleen A" sort="Meeske, Kathleen A" uniqKey="Meeske K" first="Kathleen A." last="Meeske">Kathleen A. Meeske</name>
<affiliation wicri:level="4"><inist:fA14 i1="01"><s1>Department of Preventive Medicine, Keck School of Medicine of the University of Southern California</s1>
<s2>Los Angeles, CA</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Californie</region>
<settlement type="city">Los Angeles</settlement>
</placeName>
<orgName type="university">Université de Californie du Sud</orgName>
</affiliation>
</author>
<author><name sortKey="Sullivan Halley, Jane" sort="Sullivan Halley, Jane" uniqKey="Sullivan Halley J" first="Jane" last="Sullivan-Halley">Jane Sullivan-Halley</name>
<affiliation wicri:level="4"><inist:fA14 i1="01"><s1>Department of Preventive Medicine, Keck School of Medicine of the University of Southern California</s1>
<s2>Los Angeles, CA</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Californie</region>
<settlement type="city">Los Angeles</settlement>
</placeName>
<orgName type="university">Université de Californie du Sud</orgName>
</affiliation>
<affiliation wicri:level="2"><inist:fA14 i1="02"><s1>Department of Cancer Etiology, Division of Population Sciences, City of Hope National Medical Center and Comprehensive Cancer Center, 1500 Duarte Road, Bldg. 173</s1>
<s2>Duarte, CA 91010</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Californie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Smith, Ashley W" sort="Smith, Ashley W" uniqKey="Smith A" first="Ashley W." last="Smith">Ashley W. Smith</name>
<affiliation wicri:level="2"><inist:fA14 i1="03"><s1>Applied Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute</s1>
<s2>Bethesda, MD</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Maryland</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Mctiernan, Anne" sort="Mctiernan, Anne" uniqKey="Mctiernan A" first="Anne" last="Mctiernan">Anne Mctiernan</name>
<affiliation wicri:level="2"><inist:fA14 i1="04"><s1>Cancer Prevention Research Program, Fred Hutchinson Cancer Research Center</s1>
<s2>Seattle, WA</s2>
<s3>USA</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Washington (État)</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Baumgartner, Kathy B" sort="Baumgartner, Kathy B" uniqKey="Baumgartner K" first="Kathy B." last="Baumgartner">Kathy B. Baumgartner</name>
<affiliation wicri:level="2"><inist:fA14 i1="05"><s1>Department of Epidemiology & Population Health, University of Louisville</s1>
<s2>Louisville, KY</s2>
<s3>USA</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Kentucky</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Harlan, Linda C" sort="Harlan, Linda C" uniqKey="Harlan L" first="Linda C." last="Harlan">Linda C. Harlan</name>
<affiliation wicri:level="2"><inist:fA14 i1="03"><s1>Applied Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute</s1>
<s2>Bethesda, MD</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Maryland</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Bernstein, Leslie" sort="Bernstein, Leslie" uniqKey="Bernstein L" first="Leslie" last="Bernstein">Leslie Bernstein</name>
<affiliation wicri:level="4"><inist:fA14 i1="01"><s1>Department of Preventive Medicine, Keck School of Medicine of the University of Southern California</s1>
<s2>Los Angeles, CA</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Californie</region>
<settlement type="city">Los Angeles</settlement>
</placeName>
<orgName type="university">Université de Californie du Sud</orgName>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Breast cancer research and treatment</title>
<title level="j" type="abbreviated">Breast cancer res. treat.</title>
<idno type="ISSN">0167-6806</idno>
<imprint><date when="2009">2009</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Breast cancer research and treatment</title>
<title level="j" type="abbreviated">Breast cancer res. treat.</title>
<idno type="ISSN">0167-6806</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>Arm</term>
<term>Body mass index</term>
<term>Breast cancer</term>
<term>Caucasoid</term>
<term>Diagnosis</term>
<term>Epidemiology</term>
<term>Female</term>
<term>Human</term>
<term>Hypertension</term>
<term>Lymphedema</term>
<term>Negroid</term>
<term>Race</term>
<term>Risk factor</term>
<term>Survivor</term>
<term>Woman</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Facteur risque</term>
<term>Epidémiologie</term>
<term>Bras</term>
<term>Lymphoedème</term>
<term>Cancer du sein</term>
<term>Diagnostic</term>
<term>Négroïde</term>
<term>Race</term>
<term>Homme</term>
<term>Femelle</term>
<term>Adulte</term>
<term>Femme</term>
<term>Caucasoïde</term>
<term>Survivant</term>
<term>Hypertension artérielle</term>
<term>Indice masse corporelle</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Homme</term>
<term>Adulte</term>
<term>Femme</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Purpose Lymphedema of the arm is a potential complication of breast cancer therapy. This study examines pre-disposing factors that may operate in conjunction with treatment-related factors in the development of arm lymphedema in a large cohort of White and Black breast cancer survivors. Methods 494 women (271 White and 223 Black) with in situ to Stage III-A primary breast cancer completed a baseline interview within 18 months of diagnosis. Information on lymphedema was collected during a follow-up interview, conducted on average 50 months after diagnosis. Self-reported data were used to classify women with or without lymphedema. Multivariable logistic regression models were developed to identify risk factors for arm lymphedema. Results Arm lymphedema was associated with younger age at diagnosis (odds ratio, OR per year of age = 0.96; 95% confidence interval, CI = 0.93-0.99), positive history of hypertension (OR = 2.31; 95% CI = 1.38-3.88), obesity (OR for body mass index, BMI>30 = 2.48; 95% CI = 1.05-5.84) and having had surgery where 10 or more lymph nodes were excised (OR = 2.16; 95% CI = 1.12-4.17). While Black women had higher prevalence of arm lymphedema than White women (28% vs. 21%), race was not associated with lymphedema risk in models adjusted for multiple factors (adjusted OR = 1.01; 95% CI = 0.63-1.63). Conclusion Risk of arm lymphedema did not differ significantly for Black and White women. Risk factors identified in this study offer opportunities for interventions (weight loss, control of blood pressure, use of sentinel node biopsy where possible) for reducing incidence of lymphedema or controlling the symptoms associated with this condition.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0167-6806</s0>
</fA01>
<fA02 i1="01"><s0>BCTRD6</s0>
</fA02>
<fA03 i2="1"><s0>Breast cancer res. treat.</s0>
</fA03>
<fA05><s2>113</s2>
</fA05>
<fA06><s2>2</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Risk factors for arm lymphedema following breast cancer diagnosis in Black women and White women</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>MEESKE (Kathleen A.)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>SULLIVAN-HALLEY (Jane)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>SMITH (Ashley W.)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>MCTIERNAN (Anne)</s1>
</fA11>
<fA11 i1="05" i2="1"><s1>BAUMGARTNER (Kathy B.)</s1>
</fA11>
<fA11 i1="06" i2="1"><s1>HARLAN (Linda C.)</s1>
</fA11>
<fA11 i1="07" i2="1"><s1>BERNSTEIN (Leslie)</s1>
</fA11>
<fA14 i1="01"><s1>Department of Preventive Medicine, Keck School of Medicine of the University of Southern California</s1>
<s2>Los Angeles, CA</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>7 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>Department of Cancer Etiology, Division of Population Sciences, City of Hope National Medical Center and Comprehensive Cancer Center, 1500 Duarte Road, Bldg. 173</s1>
<s2>Duarte, CA 91010</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
</fA14>
<fA14 i1="03"><s1>Applied Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute</s1>
<s2>Bethesda, MD</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
<sZ>6 aut.</sZ>
</fA14>
<fA14 i1="04"><s1>Cancer Prevention Research Program, Fred Hutchinson Cancer Research Center</s1>
<s2>Seattle, WA</s2>
<s3>USA</s3>
<sZ>4 aut.</sZ>
</fA14>
<fA14 i1="05"><s1>Department of Epidemiology & Population Health, University of Louisville</s1>
<s2>Louisville, KY</s2>
<s3>USA</s3>
<sZ>5 aut.</sZ>
</fA14>
<fA20><s1>383-391</s1>
</fA20>
<fA21><s1>2009</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>20699</s2>
<s5>354000186985230230</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2009 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>45 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>09-0141950</s0>
</fA47>
<fA60><s1>P</s1>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Breast cancer research and treatment</s0>
</fA64>
<fA66 i1="01"><s0>NLD</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>Purpose Lymphedema of the arm is a potential complication of breast cancer therapy. This study examines pre-disposing factors that may operate in conjunction with treatment-related factors in the development of arm lymphedema in a large cohort of White and Black breast cancer survivors. Methods 494 women (271 White and 223 Black) with in situ to Stage III-A primary breast cancer completed a baseline interview within 18 months of diagnosis. Information on lymphedema was collected during a follow-up interview, conducted on average 50 months after diagnosis. Self-reported data were used to classify women with or without lymphedema. Multivariable logistic regression models were developed to identify risk factors for arm lymphedema. Results Arm lymphedema was associated with younger age at diagnosis (odds ratio, OR per year of age = 0.96; 95% confidence interval, CI = 0.93-0.99), positive history of hypertension (OR = 2.31; 95% CI = 1.38-3.88), obesity (OR for body mass index, BMI>30 = 2.48; 95% CI = 1.05-5.84) and having had surgery where 10 or more lymph nodes were excised (OR = 2.16; 95% CI = 1.12-4.17). While Black women had higher prevalence of arm lymphedema than White women (28% vs. 21%), race was not associated with lymphedema risk in models adjusted for multiple factors (adjusted OR = 1.01; 95% CI = 0.63-1.63). Conclusion Risk of arm lymphedema did not differ significantly for Black and White women. Risk factors identified in this study offer opportunities for interventions (weight loss, control of blood pressure, use of sentinel node biopsy where possible) for reducing incidence of lymphedema or controlling the symptoms associated with this condition.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002B20E02</s0>
</fC02>
<fC02 i1="02" i2="X"><s0>002B12B04</s0>
</fC02>
<fC02 i1="03" i2="X"><s0>002B12B05</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Facteur risque</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Risk factor</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Factor riesgo</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Epidémiologie</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Epidemiology</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Epidemiología</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Bras</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Arm</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Brazo</s0>
<s5>03</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Lymphoedème</s0>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Lymphedema</s0>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Linfedema</s0>
<s5>04</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Cancer du sein</s0>
<s2>NM</s2>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Breast cancer</s0>
<s2>NM</s2>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Cáncer del pecho</s0>
<s2>NM</s2>
<s5>05</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Diagnostic</s0>
<s5>06</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Diagnosis</s0>
<s5>06</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Diagnóstico</s0>
<s5>06</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE"><s0>Négroïde</s0>
<s5>07</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG"><s0>Negroid</s0>
<s5>07</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA"><s0>Negroide</s0>
<s5>07</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE"><s0>Race</s0>
<s5>08</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG"><s0>Race</s0>
<s5>08</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA"><s0>Raza</s0>
<s5>08</s5>
</fC03>
<fC03 i1="09" i2="X" l="FRE"><s0>Homme</s0>
<s5>09</s5>
</fC03>
<fC03 i1="09" i2="X" l="ENG"><s0>Human</s0>
<s5>09</s5>
</fC03>
<fC03 i1="09" i2="X" l="SPA"><s0>Hombre</s0>
<s5>09</s5>
</fC03>
<fC03 i1="10" i2="X" l="FRE"><s0>Femelle</s0>
<s5>10</s5>
</fC03>
<fC03 i1="10" i2="X" l="ENG"><s0>Female</s0>
<s5>10</s5>
</fC03>
<fC03 i1="10" i2="X" l="SPA"><s0>Hembra</s0>
<s5>10</s5>
</fC03>
<fC03 i1="11" i2="X" l="FRE"><s0>Adulte</s0>
<s5>11</s5>
</fC03>
<fC03 i1="11" i2="X" l="ENG"><s0>Adult</s0>
<s5>11</s5>
</fC03>
<fC03 i1="11" i2="X" l="SPA"><s0>Adulto</s0>
<s5>11</s5>
</fC03>
<fC03 i1="12" i2="X" l="FRE"><s0>Femme</s0>
<s5>12</s5>
</fC03>
<fC03 i1="12" i2="X" l="ENG"><s0>Woman</s0>
<s5>12</s5>
</fC03>
<fC03 i1="12" i2="X" l="SPA"><s0>Mujer</s0>
<s5>12</s5>
</fC03>
<fC03 i1="13" i2="X" l="FRE"><s0>Caucasoïde</s0>
<s5>13</s5>
</fC03>
<fC03 i1="13" i2="X" l="ENG"><s0>Caucasoid</s0>
<s5>13</s5>
</fC03>
<fC03 i1="13" i2="X" l="SPA"><s0>Caucásico</s0>
<s5>13</s5>
</fC03>
<fC03 i1="14" i2="X" l="FRE"><s0>Survivant</s0>
<s5>14</s5>
</fC03>
<fC03 i1="14" i2="X" l="ENG"><s0>Survivor</s0>
<s5>14</s5>
</fC03>
<fC03 i1="14" i2="X" l="SPA"><s0>Sobreviviente</s0>
<s5>14</s5>
</fC03>
<fC03 i1="15" i2="X" l="FRE"><s0>Hypertension artérielle</s0>
<s5>15</s5>
</fC03>
<fC03 i1="15" i2="X" l="ENG"><s0>Hypertension</s0>
<s5>15</s5>
</fC03>
<fC03 i1="15" i2="X" l="SPA"><s0>Hipertensión arterial</s0>
<s5>15</s5>
</fC03>
<fC03 i1="16" i2="X" l="FRE"><s0>Indice masse corporelle</s0>
<s5>16</s5>
</fC03>
<fC03 i1="16" i2="X" l="ENG"><s0>Body mass index</s0>
<s5>16</s5>
</fC03>
<fC03 i1="16" i2="X" l="SPA"><s0>Indice masa corporal</s0>
<s5>16</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Pathologie de l'appareil circulatoire</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Cardiovascular disease</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Aparato circulatorio patología</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Pathologie des vaisseaux lymphatiques</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Lymphatic vessel disease</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Linfático patología</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Tumeur maligne</s0>
<s2>NM</s2>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Malignant tumor</s0>
<s2>NM</s2>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Tumor maligno</s0>
<s2>NM</s2>
<s5>39</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Cancer</s0>
<s2>NM</s2>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Cancer</s0>
<s2>NM</s2>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Cáncer</s0>
<s2>NM</s2>
</fC07>
<fC07 i1="05" i2="X" l="FRE"><s0>Pathologie de la glande mammaire</s0>
<s2>NM</s2>
<s5>40</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG"><s0>Mammary gland diseases</s0>
<s2>NM</s2>
<s5>40</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA"><s0>Glándula mamaria patología</s0>
<s2>NM</s2>
<s5>40</s5>
</fC07>
<fC07 i1="06" i2="X" l="FRE"><s0>Pathologie du sein</s0>
<s2>NM</s2>
<s5>41</s5>
</fC07>
<fC07 i1="06" i2="X" l="ENG"><s0>Breast disease</s0>
<s2>NM</s2>
<s5>41</s5>
</fC07>
<fC07 i1="06" i2="X" l="SPA"><s0>Seno patología</s0>
<s2>NM</s2>
<s5>41</s5>
</fC07>
<fN21><s1>096</s1>
</fN21>
<fN44 i1="01"><s1>OTO</s1>
</fN44>
<fN82><s1>OTO</s1>
</fN82>
</pA>
</standard>
</inist>
<affiliations><list><country><li>États-Unis</li>
</country>
<region><li>Californie</li>
<li>Kentucky</li>
<li>Maryland</li>
<li>Washington (État)</li>
</region>
<settlement><li>Los Angeles</li>
</settlement>
<orgName><li>Université de Californie du Sud</li>
</orgName>
</list>
<tree><country name="États-Unis"><region name="Californie"><name sortKey="Meeske, Kathleen A" sort="Meeske, Kathleen A" uniqKey="Meeske K" first="Kathleen A." last="Meeske">Kathleen A. Meeske</name>
</region>
<name sortKey="Baumgartner, Kathy B" sort="Baumgartner, Kathy B" uniqKey="Baumgartner K" first="Kathy B." last="Baumgartner">Kathy B. Baumgartner</name>
<name sortKey="Bernstein, Leslie" sort="Bernstein, Leslie" uniqKey="Bernstein L" first="Leslie" last="Bernstein">Leslie Bernstein</name>
<name sortKey="Harlan, Linda C" sort="Harlan, Linda C" uniqKey="Harlan L" first="Linda C." last="Harlan">Linda C. Harlan</name>
<name sortKey="Mctiernan, Anne" sort="Mctiernan, Anne" uniqKey="Mctiernan A" first="Anne" last="Mctiernan">Anne Mctiernan</name>
<name sortKey="Smith, Ashley W" sort="Smith, Ashley W" uniqKey="Smith A" first="Ashley W." last="Smith">Ashley W. Smith</name>
<name sortKey="Sullivan Halley, Jane" sort="Sullivan Halley, Jane" uniqKey="Sullivan Halley J" first="Jane" last="Sullivan-Halley">Jane Sullivan-Halley</name>
<name sortKey="Sullivan Halley, Jane" sort="Sullivan Halley, Jane" uniqKey="Sullivan Halley J" first="Jane" last="Sullivan-Halley">Jane Sullivan-Halley</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PascalFrancis/Checkpoint

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000307 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Checkpoint/biblio.hfd -nk 000307 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    PascalFrancis
   |étape=   Checkpoint
   |type=    RBID
   |clé=     Pascal:09-0141950
   |texte=   Risk factors for arm lymphedema following breast cancer diagnosis in Black women and White women
}}

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024

	Serveur d'exploration sur le lymphœdème
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur le lymphœdème

Risk factors for arm lymphedema following breast cancer diagnosis in Black women and White women

Risk factors for arm lymphedema following breast cancer diagnosis in Black women and White women

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri